Outset Medical Inc (OM)

EBITDA Growth

15.71%

TTM · Period ending:

OM logo

OM EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported15.71%
OM TTM EBITDA YoY % (-79.68% → 15.71%)
High-resolution chart · PNG

OM ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Outset Medical Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
15.7149%
29.1785%
41.1254%
46.0946%
49.6111%
45.0235%
36.3505%
28.3683%
13.6075%
7.1571%
-0.0983%
-1.6743%
-7.0409%
-20.0283%
-23.0492%
-34.8434%
-13.8151%
-6.0068%
-8.3836%
-11.6807%
-67.2569%
-84.1894%
-79.6843%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.